SHINE allowed more flexibility in procuring production components

May 18, 2021, 9:29AMNuclear News
SHINE executives, construction managers, and partners commemorate a construction milestone of the medical isotope production facility in March. (Photo: SHINE)

The Nuclear Regulatory Commission has approved a request by SHINE Medical Technologies for an exemption from regulations on how commercial grade equipment is defined, allowing the company to more easily procure components for the medical isotope production facility it is building in Janesville, Wis.

To continue reading, log in or create a free account!

Related Articles

MOU signed for Solo microreactor

June 23, 2025, 7:01AMNuclear News

Paragon Energy Solutions has signed a memorandum of understanding with Terra Innovatum, a developer of micro-modular nuclear reactors, to support the design and integration of instrumentation...